Mechanisms mediating reduced responsiveness of neonatal neutrophils to lipoxin A4

Pediatric Research

Volumn 64, Issue 4, 2008, Pages 393-398

  Weinberger, Barry ^a   Quizon, Cecile ^a   Vetrano, Anna M ^a   Archer, Faith ^a   Laskin, Jeffrey D ^a   Laskin, Debra L ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; LIPOXIN A; LIPOXYGENASE; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; APOPTOSIS; CHEMOTAXIS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; INFANT, NEWBORN; LIPOXINS; NEUTROPHILS; PPAR GAMMA; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

EID: 55049115509     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318180e4af     Document Type: Article

References (43)

1. Koenig JM, Yoder MC 2004 Neonatal neutrophils: the good, the bad, and the ugly. Clin Perinatal 31:39-51.
2. Savill J, Haslett C 1995 Granulocyte clearance by apoptosis in the resolution of inflammation. Semin Cell Biol 6:385-393.
3. Speer CP 2001 New insights into the pathogenesis of pulmonary inflammation in preterm infants. Biol Neonate 79:205-209.
4. Stefanutti G, Lister P, Smith VV, Peters MJ, Klein NJ, Pierro A, Eaton S 2005 P-selectin expression, neutrophil infiltration, and histologic injury in neonates with necrotizing enterocolitis. J Pediatr Surg 40:942-947 discussion 947-948.
5. Hanna N, Vasquez P, Pham P, Heck DE, Laskin JD, Laskin DL, Weinberger B 2005 Mechanisms underlying reduced apoptosis in neonatal neutrophils. Pediatr Res 57:56-62.
6. McMahon B, Godson C 2004 Lipoxins: endogenous regulators of inflammation. Am J Physiol Renal Physiol 286:F189-F201.
7. Kantarci A, Van Dyke TE 2003 Lipoxins in chronic inflammation. Crit Rev Oral Biol Med 14:4-12.
8. Bannenberg G, Moussignac RL, Gronert K, Devchand PR, Schmidt BA, Guilford WJ, Bauman JG, Subramanyam B, Perez HD, Parkinson JF, Serhan CN 2004 Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. Br J Pharmacol 143:43-52.
9. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR 2000 Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 164:1663-1667.
10. Lee TH, Horton CE, Kyan-Aung U, Haskard D, Crea AE, Spur BW 1989 Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl- L-phenylalanine. Clin Sci (Lond) 77:195-203.
11. Filep JG, Zouki C, Petasis NA, Hachicha M, Serhan CN 2002 Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 modulate adhesion molecule expression on human leukocytes in whole blood and inhibit neutrophil-endothelial cell adhesion. Adv Exp Med Biol 507:223-228.
12. Goh J, Godson C, Brady HR, Macmathuna P 2003 Lipoxins: pro-resolution lipid mediators in intestinal inflammation. Gastroenterology 124:1043-1054.
13. Jozsef L, Zouki C, Petasis NA, Serhan CN, Filep JG 2002 Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc Natl Acad Sci USA 99:13266-13271.
14. Papayianni A, Serhan CN, Brady HR 1996 Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J Immunol 156:2264-2272.
15. Serhan CN, Levy B 2003 Novel pathways and endogenous mediators in anti-inflammation and resolution. Chem Immunol Allergy 83:115-145.
16. Scannell M, Maderna P 2006 Lipoxins and annexin-1: resolution of inflammation and regulation of phagocytosis of apoptotic cells. Scientific World Journal 6:1555-1573.
17. El Kebir D, Jozsef L, Khreiss T, Pan W, Petasis NA, Serhan CN, Filep JG 2007 Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J Immunol 179:616-622.
18. Ferrante A, Thong YH 1980 Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method. J Immunol Methods 36:109-117.
19. Carr R 2000 Neutrophil production and function in newborn infants. Br J Haematol 110:18-28.
20. Madyastha PR, Glassman AB, Levine DH 1984 Incidence of neutrophil antigens on human cord neutrophils. Am J Reprod Immunol 6:124-127.
21. Weinberger B, Laskin DL, Mariano TM, Sunil VR, DeCoste CJ, Heck DE, Gardner CR, Laskin JD 2001 Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants. J Leukoc Biol 70:969-976.
22. Mohanty JG, Jaffe JS, Schulman ES, Raible DG 1997 A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J Immunol Methods 202:133-141.
23. Fierro IM, Colgan SP, Bemasconi G, Petasis NA, Clish CB, Arita M, Serhan CN 2003 Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J Immunol 170:2688-2694.
24. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN 2001 Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2:612-619.
25. Bae YS, Park JC, He R, Ye RD, Kwak JY, Suh PG, Ho Ryu S 2003 Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. Mol Pharmacol 64:721-730.
26. Chiang N, Fierro IM, Gronert K, Serhan CN 2000 Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med 191:1197-1208.
27. Flores AM, Li L, McHugh NG, Aneskievich BJ 2005 Enzyme association with PPARgamma: evidence of a new role for 15-lipoxygenase type 2. Chem Biol Interact 151:121-132.
28. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK 1999 Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 400:378-382.
29. Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C, Case T, Price J, Jack GS, Wheeler TM, Matusik RJ, Brash AR, Dubois RN 2001 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res 61:497-503.
30. Chinetti G, Fruchart JC, Staels B 2000 Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49:497-505.
31. Gupta RA, Brockman JA, Sarraf P, Willson TM, DuBois RN 2001 Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells. J Biol Chem 276:29681-29687.
32. Diamond P, McGinty A, Sugrue D, Brady HR, Godson C 1999 Regulation of leukocyte trafficking by lipoxins. Clin Chem Lab Med 37:293-297.
33. Wagner JG, Roth RA 1999 Neutrophil migration during endotoxemia. J Leukoc Biol 66:10-24.
34. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B 1999 Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 274:32048-32054.
35. Birrell MA, Patel HJ, McCluskie K, Wong S, Leonard T, Yacoub MH, Belvisi MG 2004 PPAR-gamma agonists as therapy for diseases involving airway neutrophilia. Eur Respir J 24:18-23.
36. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Maffia P, Patel NS, Di Paola R, Ialenti A, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C 2004 Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation. Eur J Pharmacol 483:79-93.
37. Kjeldsen L, Cowland JB, Borregaard N 2000 Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 1482:272-283.
38. Ryon J, Bendickson L, Nilsen-Hamilton M 2002 High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J 367:271-277.
39. Kuhn H, O'Donnell VB 2006 Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 45:334-356.
40. Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD 2005 Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol 174:5033-5039.
41. Cerasoli F Jr, Gee MH, Ishihara Y, Albertine KH, Tahamont MV, Gottlieb JE, Peters SP 1988 Biochemical analysis of the activation of adherent neutrophils in vitro. Tissue Cell 20:505-517.
42. Kantarci A, Van Dyke TE 2005 Lipoxin signaling in neutrophils and their role in periodontal disease. Prostaglandins Leukot Essent Fatty Acids 73:289-299.
43. Kantarci A, Oyaizu K, Van Dyke TE 2003 Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontal 74:66-75.